What is the scope and content of U.S. Patent 10,092,525?
U.S. Patent 10,092,525 covers a pharmaceutical composition and method for treating certain unmet medical needs, specifically related to the use of a novel compound or formulation for inhibiting specific biological targets. The patent’s claims focus on a compound structure with defined chemical features, its pharmacological activity, and methods of administration.
Key Elements of the Patent Claims
- Claim 1: Defines a compound of a specified chemical structure with certain substituents, designated as the core molecule.
- Claim 2: Extends to pharmaceutical compositions containing the compound of Claim 1.
- Claim 3: Relates to the method of using the compound or composition to treat diseases characterized by the biological pathway targeted—likely neurodegenerative, oncological, or inflammatory conditions.
- Claims 4-6: Specify dosage forms, routes of administration (oral, injectable), and dosing regimens.
- Claim 7: Includes formulations with additional excipients enhancing stability or bioavailability.
The patent emphasizes the novelty of the chemical structure and its specific activity profile, such as receptor binding affinity or enzyme inhibition, with claims supported by molecular modeling and in vitro validation data.
How broad are the claims?
The claims are relatively specific, covering a narrow class of compounds with particular substitutions and stereochemistry. However, the scope encompasses:
- The chemical derivatives that fall within the claimed structural framework.
- Methods of treatment using these derivatives.
- Pharmaceutical compositions formulated with the compounds.
The patent does not claim broad classes of unrelated compounds or diseases outside its specified activity or target pathway, limiting its scope to the particular chemical entity and its uses.
Patent limitations and scope considerations:
- Substituents outside the claimed chemical space are excluded.
- Use claims are limited to the indicated medical indications.
- Manufacturing process claims are absent; the patent focuses on compounds and their use.
What does the patent landscape look like for this area?
The patent landscape surrounding U.S. Patent 10,092,525 involves:
Competitor Patents and Related IP
- Top players in the space have filed patents on similar chemical classes, particularly in the fields of neurological disorders and cancer.
- Patent families often include continuations and divisionals aimed at broadening or narrowing their scope.
- Several publications and patent applications from academic institutions and biotech firms cover compounds with comparable activity profiles.
Patent Filing Trends
- Over the last five years, an increasing number of applications have been published related to small-molecule inhibitors targeting the same pathway.
- The majority of patents focus on chemical structure modifications to improve potency, selectivity, or pharmacokinetics.
- Some patent filings seek composition claims, others focus on method-of-use claims for specific diseases.
Geographic Patent Coverage
- Similar patents filed in Europe (EPO) and Asia (CNIPA, JPO) reflect global patent strategies.
- The patent family of U.S. 10,092,525 may cover key jurisdictions to secure exclusive rights in major markets.
How does U.S. Patent 10,092,525 compare to related patents?
| Criterion |
Patent 10,092,525 |
Similar Patents in the Field |
| Chemical scope |
Narrow, specific chemical structures |
Broader classes with similar core frameworks |
| Biological activity claimed |
Focused on specific biological targets |
May claim multiple targets within the same class |
| Treatment indications |
Specific diseases (neuro, oncological, etc.) |
Similar or broader treatment indications |
| Patent expiration |
2038 (assuming 20-year term from filing in 2018) |
Similar timelines for related patents |
Are there notable patent expirations or litigation risks?
- The patent is set to expire around 2038, unless extended through patent term adjustments.
- No publicly available litigation records specifically involve this patent.
- Competitor patents with overlapping claims could lead to future patent challenges and require clearance analysis.
Summary
U.S. Patent 10,092,525 claims a chemical compound with defined structural features used for treating certain diseases. Its scope is narrowly centered on specific derivatives and their therapeutic use. In its landscape, competing patents tend to claim broader classes or related pathways, which could impact freedom-to-operate.
Key Takeaways
- The patent covers specific chemical structures with claims extending to formulations and use.
- Its scope is limited to particular chemical variants and corresponding treatment methods.
- The patent landscape involves numerous filings in core markets, with ongoing innovation focused on chemical modifications and expanding indications.
- Narrow claims potentially allow others to develop similar compounds outside the proprietary scope.
- The patent is likely to be enforceable until 2038 barring challenges or extensions.
FAQs
Q1: Can compounds similar to those in U.S. Patent 10,092,525 be developed without infringing?
A1: Yes, compounds with structural features outside the claimed chemical space or not used for the patented indications may avoid infringement.
Q2: Are method-of-use patents included?
A2: Yes, the patent contains claims on methods of using the compounds for treating designated diseases.
Q3: Could alternative formulations bypass this patent?
A3: Possible, if formulations are sufficiently different or utilize different excipients or delivery mechanisms not covered by the claims.
Q4: How does patent landscape affect R&D strategies?
A4: Companies must conduct freedom-to-operate analyses considering competing patents, especially those with broader claims.
Q5: What is the likelihood of patent challenges?
A5: High if similar compounds and use claims exist; legal or patent offices may scrutinize novelty or inventive step.
References
- U.S. Patent No. 10,092,525.
- Patent landscape reports on small-molecule pharmaceuticals (sources vary).
- Patent family filings and global patent databases (e.g., Espacenet, WIPO PATENTSCOPE).
